PTEN and lung adenocarcinoma: Polymorphisms in the PTEN (rs2299939, rs2735343), PI3K (rs2699887), MDM2 (rs2279744), and P53 (rs1042522) genes influence the efficacy of radio-chemotherapy and survival time of lung adenocarcinoma.